| Leventhal BG, Kashima HK, Mounts P, et al | Consensus-based recommendations for the management of juvenile dermatomyositis |
|---|---|
| There was also a positive trend in increased survival in IFN gamma-1b treated patients versus the control group; this survival benefit was statistically significant in IFN gamma-1b-treated patients with mild-to-moderate disease | , IFN gamma-1b, pirfenidone, N-acetylcysteine, coumadin, bosentan, or etanercept |
6 Induration penis plastica N94.
| 0 Anogenital venereal warts C25 | Almost all patients reported at least 1 adverse event, and more patients on IFN gamma-1b group had constitutional signs and symptoms influenza-like illness, fatigue, fever, and chills than did those on placebo |
|---|---|
| Aetna considers interferon beta [Avonex interferon beta-1a , Rebif interferon beta-1a , Betaseron interferon beta-1b , Extavia interferon beta-2b ] and Plegridy peginterferon beta-1a monotherapy medically necessary for the treatment of relapsing forms of multiple sclerosis MS including relapsing-remitting and secondary progressive disease for those who continue to experience relapse | Peginterferon alpha-2a 40 kDa : An advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B |